[go: up one dir, main page]

WO2024064787A3 - Method for determination of double-stranded rna impurity - Google Patents

Method for determination of double-stranded rna impurity Download PDF

Info

Publication number
WO2024064787A3
WO2024064787A3 PCT/US2023/074734 US2023074734W WO2024064787A3 WO 2024064787 A3 WO2024064787 A3 WO 2024064787A3 US 2023074734 W US2023074734 W US 2023074734W WO 2024064787 A3 WO2024064787 A3 WO 2024064787A3
Authority
WO
WIPO (PCT)
Prior art keywords
stranded rna
double
determination
dsrna
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2023/074734
Other languages
French (fr)
Other versions
WO2024064787A2 (en
Inventor
Eddie Wang
Zheng MENG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ultragenyx Pharmaceutical Inc
Original Assignee
Ultragenyx Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ultragenyx Pharmaceutical Inc filed Critical Ultragenyx Pharmaceutical Inc
Publication of WO2024064787A2 publication Critical patent/WO2024064787A2/en
Publication of WO2024064787A3 publication Critical patent/WO2024064787A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00Reactions characterised by their quantitative nature
    • C12Q2545/10Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/101Reactions characterised by their quantitative nature the purpose being quantitative analysis with an internal standard/control

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Provided are ELISA based methods and compositions and kits for use in said methods, for quantitatively detecting the presence of double stranded RNA (dsRNA) in a sample solution, e.g., a sample solution that comprises dsRNA and messenger RNA (mRNA). Also provided are methods of correlating the presence of dsRNA with potential immunogenicity in a host.
PCT/US2023/074734 2022-09-21 2023-09-21 Method for determination of double-stranded rna impurity Ceased WO2024064787A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263376544P 2022-09-21 2022-09-21
US63/376,544 2022-09-21

Publications (2)

Publication Number Publication Date
WO2024064787A2 WO2024064787A2 (en) 2024-03-28
WO2024064787A3 true WO2024064787A3 (en) 2024-05-02

Family

ID=90455249

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/074734 Ceased WO2024064787A2 (en) 2022-09-21 2023-09-21 Method for determination of double-stranded rna impurity

Country Status (1)

Country Link
WO (1) WO2024064787A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190187031A1 (en) * 2017-12-14 2019-06-20 The Regents Of The University Of Michigan Concentration of analytes
US20190360030A1 (en) * 2002-02-21 2019-11-28 Alere San Diego Inc. Recombinase polymerase amplification

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190360030A1 (en) * 2002-02-21 2019-11-28 Alere San Diego Inc. Recombinase polymerase amplification
US20190187031A1 (en) * 2017-12-14 2019-06-20 The Regents Of The University Of Michigan Concentration of analytes

Also Published As

Publication number Publication date
WO2024064787A2 (en) 2024-03-28

Similar Documents

Publication Publication Date Title
WO2014151764A3 (en) Methods and compositions for classification of samples
EP4249605A3 (en) Methods for analyte detection
WO2001098537A3 (en) Nucleic acid accessible hybridization sites
WO2006102309A3 (en) Methods, compositions, and kits for detection of micro rna
WO2009048530A3 (en) Highly multiplexed particle-based assays
WO2006020579A3 (en) Method for rapid identification of microorganisms
WO2003060163A3 (en) Discrimination and detection of target nucleotide sequences using mass spectrometry
WO2006017083A3 (en) Methods and compositions for phenotype identification based on nucleic acid methylation
EP4498086A3 (en) Kit or device and method for detecting dementia
WO2019143943A3 (en) Composition and method for concentration and enrichment of nucleic acids
MX392762B (en) Mass spectrometry method for detection and quantitation of metabolites
AU2849300A (en) Methods and assay kits for detecting mononuclear cell phenotype
WO2022046804A3 (en) Compositions and methods for assaying proteins and nucleic acids
WO2022040106A3 (en) System and methods of detection of oncrnas for cancer diagnosis
CN103060429A (en) Flight mass spectrum biochip for innate potential assessment and its detection method
Nilsson et al. High salt buffer improves integrity of RNA after fluorescence-activated cell sorting of intracellular labeled cells
AU2015329709A1 (en) Methods and compositions relating to assays of fetal extravillous trophoblast cells
WO2003046135A3 (en) Osteopontin-related compositions and methods
EP4524152A3 (en) Hdl-associated protein biomarker panel detection
WO2023235353A3 (en) Circulating rna biomarkers for preeclampsia
MX2023003997A (en) Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle).
WO2010059914A3 (en) Nucleic acid quantification products and processes
EP1634962A4 (en) Method of detecting target nucleotide sequence, detection target structure to be used in embodying the method, process for producing the same and assay kit for detecting target nucleotide sequence
WO2024064787A3 (en) Method for determination of double-stranded rna impurity
WO2005049861A3 (en) Method for the analysis of gynaecological cell proliferative disorders

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23869167

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 23869167

Country of ref document: EP

Kind code of ref document: A2